Global Markets - G2 Intelligence

Fate of Illumina’s Grail Acquisition Remains Very Much in Doubt

It’s beginning to look like Illumina’s roll of the dice is going to come up snake eyes regarding the potential acquisition.

Start a Free Trial for immediate access to this article

Already a member? Log in here

The market is expected to grow at a CAGR of 3.21 percent from 2021 to 2028 and reach $17.432 billion by 2028, according to a recent report.

The UK-based diagnostics firm received CE marks for a diabetes test, CHF test, as well as an analyzer, and two COVID-19 tests.

The IVDR will bring around 80 percent of in vitro diagnostic medical devices under the control of so-called Notified Bodies.

While the much-delayed IVDR will take effect at the end of the month, it will be rolled out gradually.